Baidu
map
J EXP CLIN CANC RES 润色咨询

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

出版年份:1982 年文章数:2075 投稿命中率: 开通期刊会员,数据随心看

出版周期:Irregular 自引率:6.5% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

投稿信息

投稿信息
审稿费用
290.0元/篇 (网友贡献,非官方数据)
版面费用
1985.0元/篇 (网友贡献,非官方数据)
中国人发表比例
2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%)
自引率
6.5 %
年文章数
2075
期刊官网
点击查看 (点击次数:37221)
点击查看 (点击次数:21325次)
作者需知
点击查看 (点击次数:2333次)
期刊简介
稿件收录要求

Journal of Experimental & Clinical Cancer Research is an online peer-reviewed journal that publishes original research papers, reviews and commentaries in cancer research, from bench to bedside.

Journal of Experimental & Clinical Cancer Research seeks manuscripts that include significant advances in basic cancer research and that offer a translational bridge from the laboratory to the clinic to open new avenues for the understanding, prevention, diagnosis and treatment of cancer.

Specific areas of interest include, but are not limited to: mechanisms of progression of the malignant phenotype and metastatic disease; molecular alterations or biomarkers that predict response or resistance to treatment; translational research in targeted therapies; personalized medicine; novel applications of bioinformatics and biostatistics; tumor immunotherapy; large-scale molecular characterization of human tumors and innovative methods with potential applicability to clinical investigation.

The following criteria provide an overview of the types of studies considered by the journal:

  • Findings that have not been previously published in the same tumor model.
  • Studies performed in multiple cell lines.
  • Conclusions that are not representative of incremental findings.
  • Studies that include a clearly written title and abstract that communicate the study's impact of significance to non-experts.

The online appearance of Journal of Experimental & Clinical Cancer Research allows the immediate publication of accepted articles and the presentation of large amounts of data and supplemental information to ensure that new research is disseminated as efficiently and quickly as possible to the scientific community.

《实验与临床癌症研究杂志》是一份在线同行评审杂志,发表从实验室到临床的癌症研究原创研究论文、评论和评论。

实验与临床癌症研究杂志》寻求包含基础癌症研究重大进展的稿件,并提供从实验室到临床的转化桥梁,为理解、预防、诊断和治疗癌症开辟新途径。 具体感兴趣的领域包括但不限于:恶性表型和转移性疾病的进展机制;预测治疗反应或耐药性的分子改变或生物标志物;靶向治疗的转化研究;个性化医疗;肿瘤免疫治疗;人类肿瘤的大规模分子表征和可能适用于临床研究的创新方法。

以下标准概述了该期刊考虑的研究类型:

  • 在同一肿瘤模型中以前从未发表过的发现。
  • 在多种细胞系中进行的研究。
  • 结论并不代表增量发现。
  • 研究包括清晰的标题和摘要,可以向非专家传达研究的重要影响。

《实验与临床癌症研究杂志》的在线发布使得已接受的文章能够立即发表,并呈现大量数据和补充信息,以确保新的研究尽可能高效、快速地传播给科学界。

文章处理费 (APC)

在《实验与临床癌症研究杂志》上发表开放获取文章的作者需要支付文章处理费 (APC)。APC 价格将从文章被接受发表之日起确定。

当前 APC(需缴纳增值税或适用的地方税)为:2890.00 英镑/3990.00 美元/3390.00 欧元

Baidu
map
Baidu
map
Baidu
map